Treatment of rheumatoid arthritis after regression of lymphoproliferative disorders in patients treated with methotrexate: A retrospective, multi-center descriptive study: Comment on the article by Nakano K et al.
Modern Rheumatology · 2023
DOI: 10.1093/mr/roac134 ↗Kurz gefasst
Editorial in der Zeitschrift Modern Rheumatology, 2023. Verfasst von Yukitomo Urata. Beteiligte Einrichtung: Department of Rheumatology, Tsugaru General Hospital, United Municipalities of Tsugaru, Aomori, Japan. Hauptthemen laut MEDLINE: Rheumatology, Arthritis, Rheumatoid, Antirheumatic Agents, Lymphoproliferative Disorders. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 1 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Rheumatology, Tsugaru General Hospital, United Municipalities of Tsugaru, Aomori, Japan.
Zitieren
APA
Urata, Y. (2023). Treatment of rheumatoid arthritis after regression of lymphoproliferative disorders in patients treated with methotrexate: A retrospective, multi-center descriptive study: Comment on the article by Nakano K et al. Modern Rheumatology. https://doi.org/10.1093/mr/roac134
Vancouver
Urata Y. Treatment of rheumatoid arthritis after regression of lymphoproliferative disorders in patients treated with methotrexate: A retrospective, multi-center descriptive study: Comment on the article by Nakano K et al. Modern Rheumatology. 2023. doi:10.1093/mr/roac134
BibTeX
@article{Urata2023,
author = {Urata, Yukitomo},
title = {Treatment of rheumatoid arthritis after regression of lymphoproliferative disorders in patients treated with methotrexate: A retrospective, multi-center descriptive study: Comment on the article by Nakano K et al},
journal = {Modern Rheumatology},
year = {2023},
doi = {10.1093/mr/roac134}
}
EUVIMED